Categories AlphaGraphs, Earnings, Health Care

Johnson & Johnson beats in Q2; raises FY guidance

Johnson & Johnson (NYSE: JNJ) reported second-quarter 2021 financial results before the regular market hours on Wednesday. The pharmaceutical giant reported Q2 sales of $23.3 billion, up 27% year-over-year and higher than the Wall Street projection. Net income of $2.48 per share was also above the target that analysts had anticipated.

JNJ shares were trading flat immediately following the announcement. The stock has gained 7.6% since the beginning of this year.

 johnson & Johnson Q2 2021 earnings

Looking forward to listening to management/analyst comments on the results? Stay tuned here for Johnson & Johnson Q2 earnings call transcript

Prior performance

  • Johnson & Johnson Q4 2020 earnings
  • Johnson & Johnson Q3 2020 earnings
  • Johnson and Johnson reports Q2 2020 earnings results

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q3 2024

Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to

Key highlights from Exxon Mobil Corporation’s (XOM) Q3 2024 earnings results

Exxon Mobil Corporation (NYSE: XOM) reported its third quarter 2024 earnings results today. Total revenues and other income remained relatively flat at $90 billion compared to the same period a

AAPL Earnings: Apple Q4 2024 sales rise 6% YoY, beat estimates

Apple Inc. (NASDAQ: AAPL) reported an increase in revenues for the fourth quarter of 2024. The top line came in above estimates. The gadget giant generated revenues of $94.9 billion

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top